¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"alpha chain disease"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • Minamata disease
    ¹Ì³ª¸¶Å¸º´
  • miner¡¯s disease
    ±¤ºÎº´
  • minimal change disease
    ¹Ì¼¼º¯È­º´
  • malabsorption disease
    Èí¼öÀå¾Öº´
  • mixed connective tissue disease
    È¥ÇÕ°áÇÕÁ¶Á÷º´
  • molecular disease
    ºÐÀÚº´
  • Monge disease
    ¸ùÇ캴
  • motor neuron disease
    ¿îµ¿½Å°æ¼¼Æ÷º´, ¿îµ¿½Å°æ¿øº´
  • mountain disease
    °í»êº´
  • moyamoya disease
    ¸ð¾ß¸ð¾ßº´
  • muscle disease
    ±ÙÀ°º´
  • mycobacterial disease
    Ç×»ê±Õº´, ¹ÌÄÚ¹ÚÅ׸®¾Æº´
  • mycoplasma disease
    ¹ÌÄÚÇö󽺸¶º´
  • maple syrup urine disease
    ´Üdz½Ã·´´¢º´
  • marble bone disease
    ´ë¸®¼®º´, °ñÈ­¼®º´
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • neurohypophysial disease
    ½Å°æ³úÇϼöüº´
  • neuromuscular disease
    ½Å°æ±ÙÀ°º´
  • neuronal storage disease
    ½Å°æ¼¼Æ÷ÀúÀ庴
  • neuropathic joint disease
    ½Å°æº´Áõ°üÀýº´
  • notifiable disease
    ½Å°í´ë»óÁúº´
  • nutritional disease
    ¿µ¾çº´
  • nutritional deficiency disease
    ¿µ¾ç°áÇ̺´
  • obliterative arterial disease
    Æó»öµ¿¸Æº´
  • obstructive pulmonary disease
    Æó¼âÆóº´
  • occlusive cerebrovascular disease
    Æó¼â³úÇ÷°üÁúȯ
  • occupational disease
    Á÷¾÷º´
  • occupational dental disease
    Á÷¾÷Ä¡°úº´
  • oculoglandular disease
    ´«»ùº´
  • oral disease
    ÀÔº´, ±¸°­Áúȯ
  • organic disease
    ±âÁúº´
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • VDRL test= venereal disease research laboratory test
    ¼ºº´¿¬±¸¼Ò½ÄÅ×½ºÆ®.
  • VDRL test= venereal disease research laboratory test
    ¼ºº´¿¬±¸¼Ò½ÄÅ×½ºÆ®.
  • Von Recklinghausens disease(neurofibromatosis)
    Æù·¹Å¬¸µÇÏ¿ìÁ¨º´<½Å°æ¼¶À¯Á¾Áõ>.
  • Weber Christian disease
    ¿þ¹ö-Å©¸®½º Ä£º´.
  • Weils disease
    ¿ÍÀϺ´(Ȳ´ÞÃâÇ÷¼º ·¾Å佺ÇǶóÁõ).
  • Weils disease
    ¿ÍÀϺ´(Ȳ´ÞÃâÇ÷¼º ·¾Å佺ÇǶóÁõ).
  • Weils disease
    ¿ÍÀϺ´(Ȳ´ÞÃâÇ÷¼º ·¾Å佺ÇǶóÁõ).
  • Wernicke s disease
    º£¸£´ÏÄɺ´.
  • Wernickes disease
    º£¸£´ÏÄɺ´.
  • Wilsons disease
    Àª½¼º´
  • accumulation disease
    ÃàÀûº´(õëîÝÜ»).
  • acquired cystic disease of the kidney
    ÈÄõ¼º ½Å³¶Æ÷Áúȯ
  • acquired disease
    ÈÄõ¼º Áúº´(¡­òðÜ»).
  • acquired heart disease =AHD
    ÈÄõ¼º ½ÉÁúȯ(¡­ãýòðü´).
  • acute demyelinating disease
    ±Þ¼º Å»¼öÃʼº Áúȯ(¡­÷­âÐõ¦àõòðü´).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • breast,fibrocystic disease
    ¼¶À¯ ³¶¼º Áúȯ(àéë«Ò¥àõòðü´)
  • bridegrooms disease
    ½Å¶ûº´(ãæÕÍÜ»)
  • brill-zinsser disease
    ºê¸±ÂðÀúº´ (¡­Ü»)
  • brittle bone disease
    ÆÄ¼â°ñ (÷òáïÍé)
  • broad beta disease
    ±¤º£Å¸º´
  • buergers disease
    ¹ö°Å º´ (¡­Ü»)
  • buffalo disease
    ¹°¼Ò³ú¿°(¡­Òàæú).
  • bullous disease
    ¼öÆ÷¼º Áúȯ(â©øÞàõ òðü´)
  • bullous disease
    ¼öÆ÷¼º Áúȯ
  • cadmium workers disease
    Ä«µå¹ÅÁ÷°øº´(ÊṲ̀˭ËÓ).
  • caisson disease
    ÀáÇÔº´(íÖùæÜ»)
  • caisson disease
    ÀáÇÔº´(íÖùÞÜ»), Àá¼öº´(íÖâ©Ü»)
  • caisson disease =decompression sickness
    ÀáÇÔº´(Ëö̰ËÓ)ÊÙ°¨¾Ðº´ÊÙ.
  • calcific mitral disease
    ¼®È¸È­½Â¸ðÆÇ¸·Áúȯ(à´üéûùã¬Ù¶÷ýدòðü´).
  • calcific mitral disease
    ¼®È¸È­½Â¸ðÆÇ¸·Áúȯ(¡­ã¬Ù¶÷ûدòðü´).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 17
L-cFA long chain fatty acid
LCMG long-chain monoglyceride
LCP long-chain polysaturated [fatty acid]; lymphocyte cytosol polypeptide
LCT liver cell tumor; long-chain triglyceride; lymphocytotoxicity; lymphocytotoxin
LHB luteinizing hormone beta chain
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 17
alpha-T Alpha-tocopherol
alpha-Toc Alpha-tocopherol
alpha-TTP Alpha-tocopherol transfer protein
TNF alpha Anti-tumour necrosis factor alpha
anti-TNF alpha Anti-tumor necrosis factor alpha
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • Perrin-Ferraton disease
    Æä·©-Æä¶óÅë º´
    µ¿ÀǾî=sna
  • Perthes' disease
    Æä¸£Å×½ºº´
  • Peutz-Jeghers-Klostermann disease
    Peutz-Jeghers-Klostermann º´
  • pick's disease
    ÇÈ Áúȯ
    ³úÀÇ µå¹® ÁøÇ༺ ÅðÇ༺ ÁúȯÀ¸·Î¼­ ¾ËÂêÇÏÀ̸Ӻ´°ú ´ë´ÜÈ÷ ºñ½ÁÇÑ ÀÓ»óÀû Áõ»ó°ú °æ°ú¸¦ ³ªÅ¸³»³ª, ¶Ñ·ÇÀÌ ´Ù¸¥ Á¶Á÷º´¸®ÇÐÀû ¼Ò°ßÀ» °¡Áö°í ÀÖ´Ù. ÇÇÁú À§ÃàÀÌ ÀüµÎ¿±°ú ÃøµÎ¿±¿¡ ±¹ÇѵǾî ÀÖÀ¸¸ç, ÅðÇàµÈ ´º·Ð¿¡´Â ±¸»óÀÇ ¼¼Æ÷Áú ³» »ç»ó ºÀÀÔü¸¦ ÇÔÀ¯Çϰí ÀÖ´Ù.
  • polycystic disease
    ´Ù³¶¼º Áúȯ
  • polycystic kidney disease
    ´Ù³¶ ½Å Áúȯ
  • polycystic ovarian disease
    ´Ù³¶ ³­¼Ò Áúȯ
  • polyendocrine autoimmune disease
    ´Ù³»ºÐºñ¼± ÀÚ°¡ ¸é¿ª Áúȯ
    µ¿ÀǾî=autoimmune
  • Pospischill-Feyrter disease
    Pospischill-Feyrter º´
  • Preiser's disease
    Preiser º´
  • prenatal disease
    Ãâ»ý Àü Áúȯ
    žƱ⠶§ Áúº´À» °¡Áö´Â »óÅÂ.
  • previous dental disease
    ÀÌÀüÀÇ Ä¡°ú Áúȯ
  • professional disease
    Àü¹®Á÷º´, Á÷¾÷º´
  • progress of disease
    º´ÀÇ °æ°ú, º´ÀÇ ÁøÇà
    Áúº´ÀÌ ¾ÕÀ¸·Î ÁøÇàÇÏ¿© ¿øÇÏÁö ¾Ê´Â °á°ú¸¦ ÃëÇÏ´Â °Í
  • psychological disease
    ½É¸® Áúȯ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
receptors, adrenergic, alpha-1 A subclass of alpha-adrenergic receptors (receptors, adrenergic, alpha). Alpha-1 adrenergic receptors can be pharmacologically discriminated, e.g., by their high affinity for the agonist phenylephrine and the antagonist prazosin. They are widespread, with clinically important concentrations in the liver, the heart, vascular, intestinal, and genitourinary smooth muscle, and the central and peripheral nervous systems.
(12 Dec 1998)
receptors, adrenergic, alpha-2 A subclass of alpha-adrenergic receptors (receptors, adrenergic, alpha). Alpha-2 adrenergic receptors can be pharmacologically discriminated, e.g., by their high affinity for the agonist clonidine and the antagonist yohimbine. They are found on pancreatic beta cells, platelets, and vascular smooth muscle, as well as both pre- and postsynaptically in the central and peripheral nervous systems.
(12 Dec 1998)
receptors, antigen, T-cell, alpha-beta T-cell receptors composed of CD3-associated alpha and beta polypeptide chains and expressed primarily in CD4+ or CD8+ T-cells. Unlike immunoglobulins, the alpha-beta T-cell receptors recognise antigens only when presented in association with major histocompatibility (MHC) molecules.
(12 Dec 1998)
maternal serum alpha-fetoprotein A plasma protein, alpha-fetoprotein (afp) is normally produced by the foetus. The level of afp in the blood serum of pregnant women provides a screening test for open neural tube defects (anencephaly and spina bifida) and for down syndrome (and other chromosome abnormalities). The maternal serum afp (msafp) tends to be unusally high with open neural tube defects and unsually low with down syndrome.
(12 Dec 1998)
glucan 1,4-alpha-glucosidase <enzyme> An enzyme that catalyses the hydrolysis of terminal 1,4-linked alpha-d-glucose residues successively from non-reducing ends of polysaccharide chains with the release of beta-glucose. It is also able to hydrolyze 1,6-alpha-glucosidic bonds when the next bond in sequence is 1,4.
Chemical name: 1,4-alpha-D-Glucan glucohydrolase
Registry number: EC 3.2.1.3
(12 Dec 1998)
glucan 1,4-alpha-maltohexaosidase <enzyme> From klebsiella pneumoniae; hydrolyzes 1,4-alpha-d-glucosidic linkages in amylaceous polysaccharides so as to remove successive maltohexaose residues from the non-reducing ends
Registry number: EC 3.2.1.98
Synonym: exo-maltohexao-hydrolase, extracellular maltohexaose-forming amylase, bacillus maltohexaose-forming amylase, g6-amylase
(26 Jun 1999)
glucan 1,6-alpha-isomaltosidase <enzyme> Hydrolyzes 1,6-alpha-d-glucosidic linkages in polysaccharides so as to remove successive isomaltose units from the non-reducing ends of the chains; from arthrobacter globiformis; mw 66 kD; genbank d30761
Registry number: EC 3.2.1.94
Synonym: isomalto-dextranase, 1,6-alpha-d-glucan isomaltohydrolase, imd gene product, exo-isomaltohydrolase
(26 Jun 1999)
cephalosporin 7-alpha-hydroxylase <enzyme> A dioxygenase from streptomyces clavuligerus; requires 2-oxoglutarate, fe2+ and a reducing agent such as ascorbic acid
Registry number: EC 1.14.11.-
(26 Jun 1999)
glycopeptide alpha-N-acetylgalactosaminidase <enzyme> Hydrolyzes terminal d-galactosyl-n-acetyl-alpha-d-galactosaminide residues from glycopeptides and glycoproteins linked by serine or threonine residues
Registry number: EC 3.2.1.97
Synonym: o-glycanase
(26 Jun 1999)
glycoprotein endo-alpha-1,3-mannosidase <enzyme> An endomannosidase; cleaves glucosyl alpha1-3-mannose from monoglucosylated oligosaccharide (glcman(7-9)glcnac) of the glycoprotein produced in the golgi membrane
Registry number: EC 3.2.1.130
Synonym: glucosyl mannosidase
(26 Jun 1999)
glycoprotein hormones, alpha subunit A non-covalently bound subunit of the glycoprotein hormones tsh, fsh, lh, and hcg which originates in the anterior pituitary gland and placenta. This subunit is virtually identical in structure and indistinguishable by radioimmunoassay in all of the above glycoproteins. It is present in both men and women, but is elevated in postmenopausal women and in patients with hypothyroidism, uraemia and malignant tumours. The alpha subunit may be involved directly in recognition of certain receptors.
(12 Dec 1998)
glycosylated alpha-amylase <enzyme> Contains a single biantennary n-linked oligosaccharide that terminates with the structure fucalpha1,3(galbeta1,4)glcnac
Registry number: EC 3.2.1.-
Synonym: human glycosylated alpha-amylase
(26 Jun 1999)
peptide N-alpha acetyltransferase <enzyme> Pituitary enzyme; acetylates peptide hormones including acth; also found in saccharomyces cerevisiae
Registry number: EC 2.3.1.88
Synonym: peptide acetyltransferase, acth acetyltransferase, beta-endorphin acetyltransferase, alpha-msh acetyltransferase
(26 Jun 1999)
Goodenough draw-alpha-man test A brief test for assessing an individual's level of intelligence based on how accurately drawn and how many elements are included when a child or adult is given a pencil and sheet of white paper and asked to draw a man, the best man he or she is able to draw. Also called the Goodenough draw-alpha-person test and, in its current form, the Goodenough-Harris drawing test.
(05 Mar 2000)
cholesterol 7 alpha-monooxygenase <enzyme> An enzyme that catalyses the hydroxylation of cholesterol to cholest-5-en-3 beta,7 alpha-diol.
Chemical name: Cholesterol,NADPH:oxygen oxidoreductase (7 alpha-hydroxylating)
Registry number: EC 1.14.13.17
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 17
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 17
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 17
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 17
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 17
ÅëÇÕ°Ë»ö ¿Ï·á